NIH’s 2013 Budget Cuts Announced

The agency released details of the sequester’s effects.

Written byKate Yandell
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

FLICKR, PEN WAGGENERThe numbers are in on the extent of the National Institutes of Health (NIH) budget cuts for 2013, ScienceInsider reported. As expected, due to the sequester the agency’s budget fell by $1.55 billion to a total of $29.15 billion for the year, a 5 percent cut.

The agency would have awarded 34,902 grants but is eliminating 1,357 of those, including 703 that would have been for new competing grants. The rest of the grants cut would have been extensions of previously funded research.

The NIH had already reduced some continuing awards by 10 percent, and the agency said that while some of those funds could possibly be restored, the grants would likely continue to be funded below their originally intended levels. Furthermore, the NIH has promised to increase ongoing grants each year with inflation in the past, but starting with grants awarded in 2012 it will no longer do so.

NIH Director Francis Collins took to Twitter to express his frustration with the cuts, soliciting researchers to tell their tales of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies